Hydroxyapatite-ceramic-coated femoral components in young patients followed-up for 16 to 19 years
N. N. Shah, A. J. Edge, D. W. Clark
Category: Furlong Clinical Results
From Worthing and Southlands Hospitals NHS Trust, Shoreham-by-Sea, England
In 2004 we described the ten-year prospective results of 38 total hip replacements using the Furlong hydroxyapatite-ceramic-coated femoral component in 35 patients < 50 years old. We have now reviewed the surviving 35 arthroplasties in 33 patients at a mean of 16 years (10.3 to 19.9). The mean age of the surviving patients at the time of operation was 41.3 years (26.0 to 49.0). Of these, eight have undergone revision of their acetabular component for aseptic loosening. None of the femoral components has had revision for aseptic loosening giving a survival rate of 100% at 16 years (95% confidence interval 89% to 100%). The Furlong hydroxyapatite-ceramic-coated femoral component gives excellent long-term survival in young and active patients.
The Journal of Bone and Joint Surgery
J Bone Joint Surg [Br]
VOL. 91-B, No. 7, JULY 2009